| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 496.8 | 450.2 | 429.2 |
| Other income | 8.5 | 5.1 | 0.9 |
| Total income | 505.3 | 455.3 | 430.1 |
| Profit before exceptional items & tax | 102.5 | 77.7 | 71.0 |
| Profit before tax | 102.5 | 77.7 | 71.0 |
| Net profit | 75.5 | 56.9 | 52.9 |
| Operating margin | 20.3% | 17.1% | 16.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +42.70% |
|---|---|
| Net profit, quarter on quarter | +32.70% |
| Revenue, year on year | +15.80% |
| Operating profit, year on year | +34.10% |
| Operating profit, quarter on quarter | +29.50% |
BSE results filing, NSE: METROPOLIS. Figures extracted from the filing.
Metropolis Healthcare Ltd: key numbers
- Share price
- ₹568.70
- Market cap
- ₹11,798 Cr
- Revenue (annual)
- ₹1,646 Cr
- Net profit (annual)
- ₹190.0 Cr
- P/E (TTM)
- 58.5×Sector 53.7×
- Promoter holding
- 47.82%-1.04% QoQ
- FII holding
- 11.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Metropolis Healthcare Ltd
All →Metropolis Healthcare Dividend
Metropolis Healthcare declared an interim dividend of ₹1 per equity share for FY 26-27. The record date is 9 November 2026.
Metropolis Healthcare Results Update
Metropolis Healthcare posted Q2 FY27 revenue up 16% to ₹497 crore and PAT up 43% to ₹75 crore. Board declared a ₹1 per share interim dividend.
Metropolis Healthcare Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 497 Cr (+16% YoY), EBITDA INR 135 Cr at 27.2% margin, PAT INR 75 Cr (+43%). H1 revenue INR 947 Cr (+16%). Strategy is Metropolis 3.0, focused on tech, science and profitable growth.
Metropolis Healthcare Employee Stock Options
Metropolis Healthcare granted 24,060 RSUs and 3,58,920 ESOPs under its 2025 plans, and allotted 65,600 shares under its RSU Plan 2020.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Metropolis Healthcare Other Announcement
Metropolis Healthcare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure provides details on the company's equity share distribution.